Massachusetts General Hospital Psychiatry Academy

Year Up Appoints Three New Members to Its National Board of Directors

Retrieved on: 
Tuesday, September 26, 2023
Private banking, Learning, Duke University, Harvard Kennedy School, University, Business Insider, U.S. Department of Defense Strategy for Operating in Cyberspace, Culture, Vertex, DC, Massachusetts General Hospital Psychiatry Academy, MBA, Trustee, Reardon, Council, Harvard Business School, McKinsey & Company, International development, Presidency of Barack Obama, Boston University School of Public Health, Term, Bank of America, Ginkgo Bioworks, Acquisition, Foreign policy, Champaign–Urbana metropolitan area, Randomized controlled trial, Goodman, HR, Climate, MPA, Boston Business Journal, Bank, Hospital, Regional bank, PACE, Native American policy of the Barack Obama administration, United, Management, Education

BOSTON, Sept. 26, 2023 /PRNewswire/ -- The national workforce development organization Year Up announced today that it has appointed three new members to its national board of directors, which meets quarterly in support of Year Up's mission to close the Opportunity Divide. Vertex CEO and President Reshma Kewalramani, Bank of America Human Resources Executive Karen Reardon, and McKinsey & Company Associate Partner Jared Goodman attended their first board meeting on September 18, 2023.

Key Points: 
  • "These are seasoned business leaders who have demonstrated strong commitment to advancing equitable access to opportunity," said Year Up Founder and CEO Gerald Chertavian.
  • She currently serves on the Biomedical Science Careers Program's board of directors, the Massachusetts General Hospital board of trustees, the Boston University School of Medicine Dean's Advisory Board and the Ginkgo Bioworks board of directors.
  • She received her medical degree from the Boston University School of Medicine and is a Harvard Business School graduate.
  • She oversees leadership development, talent acquisition, learning, employee relations, compensation, diversity and inclusion, change management, manager effectiveness and performance management.

The Fenway Institute Paper Shows National Tele-Education Program Expands Access to Transgender and Gender Diverse Health Care

Retrieved on: 
Monday, March 27, 2023
LGBT, Primary health care, HIV, Massachusetts General Hospital Psychiatry Academy, Community Healthcare Network, Extension, Social, Project Echo, SM, Patient, Practitioner, Physician, Knowledge, TGD, Mental health, Healthcare and the LGBT community, Fenway Health, Nursing

BOSTON, March 27, 2023 /PRNewswire-PRWeb/ -- A paper published in LGBT Health reports on the outcomes of TransECHO, a professional development and training program for primary care teams on the provision of gender-affirming integrated medical and behavioral health for transgender and gender diverse (TGD) patients. The paper suggests that TransECHO has helped fill gaps in training on TGD primary medical and behavioral health care.

Key Points: 
  • The paper suggests that TransECHO has helped fill gaps in training on TGD primary medical and behavioral health care.
  • "To minimize these disparities, medical and behavioral health providers need access to robust continuing professional development on gender-affirming health care."
  • TransECHO is based on Project ECHO (Extension for Community Healthcare Outcomes), a tele-education program for health care providers designed to reduce health disparities and increase access to specialty care in underserved areas.
  • "Given the persistent inequities in health outcomes experienced by transgender and gender diverse patients, access to high-quality professional development and training in gender-affirming health care is a necessity for medical and behavioral health providers," said study author Hilary Goldhammer, SM.

New Study from The Fenway Institute Undercuts the Rapid Onset Gender Dysphoria Hypothesis

Retrieved on: 
Monday, March 20, 2023
National Center for Transgender Equality, Risk, Gender identity, University, Suicidal ideation, Transgender, Massachusetts General Hospital Psychiatry Academy, Parent, Policy, Disclosure, Gender variance, Health, Economist, JAMA Surgery, Public policy, ROGD, Impact of the COVID-19 pandemic on neurological, psychological and other mental health outcomes, History, Health policy, Bentham Science Publishers, Puberty, Journal, Assistant professor, Publication, Standards of Care for the Health of Transgender and Gender Diverse People, Adolescent health, Division, The New York Times, Manuscript, Psychiatry, Adolescence, Realization, Transgender youth, Turban, Faculty, TGD, Healthcare and the LGBT community, JAMA Psychiatry, Female, Fenway Health, Toy, Nursing, Science, Pediatrics

BOSTON, March 20, 2023 /PRNewswire-PRWeb/ -- A study published in the Journal of Adolescent Health found that a substantial proportion of transgender and gender diverse (TGD) adults realized that their gender identity is different from their sex assigned at birth during adolescence or later. It also found that TGD people typically waited many years before sharing this realization with another person. The study adds important new knowledge to clinical and popular understanding of the timing of TGD people's awareness, understanding, and sharing of their gender identity. It also undercuts a core component of the "rapid onset gender dysphoria" (ROGD) hypothesis, which posits that TGD identities realized in adolescence are transient and will not continue into adulthood.

Key Points: 
  • The study adds important new knowledge to clinical and popular understanding of the timing of TGD people's awareness, understanding, and sharing of their gender identity.
  • It also undercuts a core component of the "rapid onset gender dysphoria" (ROGD) hypothesis, which posits that TGD identities realized in adolescence are transient and will not continue into adulthood.
  • Participants were also asked how old they were when they first shared their gender identity with another person.
  • Published in Pediatrics, that study provided evidence undercutting the "social contagion" component of the ROGD hypothesis.

NKGen Biotech Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Natural Killer Cell Therapies Targeting Neurodegenerative Diseases

Retrieved on: 
Wednesday, March 8, 2023
NINDS, Immune system, Research, Inflammation, Pharmacology, Harvard Medical School, Laurie, Central nervous system, Brain damage, UCLA, Cell biology, University, DSM-IV codes, Multiple sclerosis, Hospital, SAB, Biotechnology, Massachusetts General Hospital Psychiatry Academy, Bangladesh Technical Education Board, Brain, Patient, Coronavirus Scientific Advisory Board, CNS, NK, University of Chicago Medical Center, National Institute of Neurological Disorders and Stroke, Tic disorder, Neurodegenerative disease, NIH, Vaccine, Pharmaceutical industry, Neurology, Neuroscience

The newly formed SAB will provide strategic, scientific, and clinical guidance as the Company progresses its pipeline of innovative natural killer cell therapies targeting neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.

Key Points: 
  • The newly formed SAB will provide strategic, scientific, and clinical guidance as the Company progresses its pipeline of innovative natural killer cell therapies targeting neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
  • “We are honored to welcome such esteemed experts in the field of neurological disease to our Scientific Advisory Board,” commented Paul Y.
  • “Each brings their own respective scientific and clinical expertise in key areas including Alzheimer’s, Parkinson’s, Multiple Sclerosis, and neuroinflammation.
  • Dr. Guo is a renowned investigator in neurological disorders, with an emphasis on neurodegenerative diseases including Alzheimer’s and Parkinson’s disease.

The Fenway Institute: Viability of gender-affirming health care linked with policies and institutions that protect the rights of transgender and gender diverse people

Retrieved on: 
Wednesday, December 21, 2022
Mastectomy, Massachusetts General Hospital Psychiatry Academy, Commentary, Risk, Habakkuk Commentary, Nature Medicine, Imprisonment, Science, Breast augmentation, Research, Gender identity, Medicine

BOSTON , Dec. 21, 2022  /PRNewswire-PRWeb/ -- A commentary published online in Nature Medicine documents the context, science, and practice of gender-affirming health care over the last century and argues that the viability of gender-affirming health care is inextricably linked with governmental policies, institutions, and structures that protect and support the rights, dignity, inclusion and belonging of all transgender and gender diverse people. It also asserts that gender-affirming health care must be inclusive, community led, and evidence informed.

Key Points: 
  • It also asserts that gender-affirming health care must be inclusive, community led, and evidence informed.
  • Research also shows that transgender and gender diverse people rarely discontinue pursuing gender affirmation when they have the option to maintain it.
  • Including transgender and gender diverse people in the evolution of gender-affirming care by respecting their autonomy.
  • "We also require leadership from clinicians and public officials advocating against politically motivated attempts to block access to gender-affirming health care and denigrate the rights and dignity of transgender and gender diverse people in civic life."

The Fenway Institute: We must replace psychiatric gatekeeping with informed consent for gender-affirming surgery

Retrieved on: 
Thursday, December 15, 2022
Rhinoplasty, Surgeon, Letter, Patient, JAMA Surgery, Viewpoint, Breast augmentation, Massachusetts General Hospital Psychiatry Academy, Mental health, CQD, Birth control, Dentistry, Medicine, Hospital

BOSTON, Dec. 14, 2022 /PRNewswire-PRWeb/ -- A Viewpoint published in JAMA Surgery asserts that requiring gender-affirming surgical adult patients to obtain an assessment letter prior to surgery is an unnecessary barrier to care and that moving toward an informed consent model, which is in place for nearly all other surgical procedures, would benefit such patients. The prior standard requiring assessment of suitability for surgery by a mental health care professional was designed to prevent regret about undergoing surgical procedures. In practice, patient regret for gender-affirming surgical procedures is very rare, and there is no evidence that presurgical mental health screening reduces rates of regret.

Key Points: 
  • The requirement for presurgical assessment for patients seeking gender-affirming surgery differs markedly from the informed consent model that is used for nearly all other surgical procedures.
  • With informed consent, surgeons talk with patients about their goals for surgery as well as the benefits and risks of surgery.
  • "Moving toward a model of informed consent for gender-affirming surgery will increase access to this medically necessary care, while also minimizing the harm caused by psychiatric gatekeeping."
  • "Moving Beyond Psychiatric Gatekeeping for Gender-Affirming Surgery," was published online by JAMA Surgery on December 14, 2022.

Paper from The Fenway Institute Describes Novel Medical School Training That Prepares Students To Become Physician-Leaders in LGBTQIA+ Health

Retrieved on: 
Tuesday, November 29, 2022
Dermatology, Intersex, Obstetrics, Massachusetts General Hospital Psychiatry Academy, Health minister, Association of American Medical Colleges, Harvard Medical School, Student, LGBT, Health, Healthcare and the LGBT community, Patient, Endocrinology, Gynaecology, HIV, Medicine

BOSTON, Nov. 29, 2022 /PRNewswire-PRWeb/ -- A paper published in LGBT Health reports on the impact of a four-week elective course at Harvard Medical School that prepares students to become physician-leaders in LGBTQIA+ health care. The course is one of the few available to medical students that provides opportunities for direct care experiences with patients, mentored scholarship, and instruction across a variety of medical specialties and patient age ranges. The paper suggests that the course can serve as a model for how to structure meaningful training experiences for medical students interested in becoming physician-leaders in LGBTQIA+ health care.

Key Points: 
  • BOSTON, Nov. 29, 2022 /PRNewswire-PRWeb/ -- A paper published in LGBT Health reports on the impact of a four-week elective course at Harvard Medical School that prepares students to become physician-leaders in LGBTQIA+ health care.
  • The paper suggests that the course can serve as a model for how to structure meaningful training experiences for medical students interested in becoming physician-leaders in LGBTQIA+ health care.
  • Between January 2016 and February 2022, 30 medical students completed the LGBTQIA+ health elective course.
  • "Our findings suggest that this course can serve as a model for how to structure meaningful training experiences for medical students."

Gilde Healthcare establishes world-leading Impact Council

Retrieved on: 
Tuesday, November 29, 2022
Newton, GDP, Medical Products Agency (Sweden), Pharmaceutical industry, European Medicines Agency, Mass, Patient, Private equity, Conditional sentence, NICE, Policy, Union, Medicines Discovery Catapult, Hospital, Health care, Massachusetts General Hospital Psychiatry Academy, Harvard Medical School, EMA, Medtech, Newton-Wellesley Hospital, Pharmacist, Executive Committee, ICER, Association of British HealthTech Industries, Association of the British Pharmaceutical Industry, Assistant, CADTH, Tufts Medical Center, General partnership, Division, Medical device, Management, Health insurance, Medicine, Humana

UTRECHT, Netherlands, Nov. 29, 2022 /PRNewswire/ -- Gilde Healthcare, the specialized healthcare investor with 2 billion raised in dedicated sector funds, today announced the establishment of the Gilde Healthcare Impact Council.

Key Points: 
  • UTRECHT, Netherlands, Nov. 29, 2022 /PRNewswire/ -- Gilde Healthcare, the specialized healthcare investor with 2 billion raised in dedicated sector funds, today announced the establishment of the Gilde Healthcare Impact Council.
  • Chaired by Professor Guido Rasi, former Executive Director of the European Medicines Agency (EMA), the Impact Council will play a pivotal role in assessing the impact on the healthcare system by Gilde Healthcare and its Venture&Growth portfolio companies.
  • Joep Muijrers, General Partner at Gilde Healthcare and responsible within Gilde Healthcare for coordinating the Impact Council, commented: "We are honoured to be working with such an established and experienced group of experts.
  • Pieter van der Meer, Managing Partner at Gilde Healthcare commented: "The Impact Council demonstrates our commitment to effectuate change in the healthcare sector.

Gilde Healthcare establishes world-leading Impact Council

Retrieved on: 
Tuesday, November 29, 2022
Newton, GDP, Medical Products Agency (Sweden), Pharmaceutical industry, European Medicines Agency, Mass, Patient, Private equity, Conditional sentence, NICE, Policy, Union, Medicines Discovery Catapult, Hospital, Health care, Massachusetts General Hospital Psychiatry Academy, Harvard Medical School, EMA, Medtech, Newton-Wellesley Hospital, Pharmacist, Executive Committee, ICER, Association of British HealthTech Industries, Association of the British Pharmaceutical Industry, Assistant, CADTH, Tufts Medical Center, General partnership, Division, Medical device, Management, Health insurance, Medicine, Humana

UTRECHT, Netherlands, Nov. 29, 2022 /PRNewswire/ -- Gilde Healthcare, the specialized healthcare investor with 2 billion raised in dedicated sector funds, today announced the establishment of the Gilde Healthcare Impact Council.

Key Points: 
  • UTRECHT, Netherlands, Nov. 29, 2022 /PRNewswire/ -- Gilde Healthcare, the specialized healthcare investor with 2 billion raised in dedicated sector funds, today announced the establishment of the Gilde Healthcare Impact Council.
  • Chaired by Professor Guido Rasi, former Executive Director of the European Medicines Agency (EMA), the Impact Council will play a pivotal role in assessing the impact on the healthcare system by Gilde Healthcare and its Venture&Growth portfolio companies.
  • Joep Muijrers, General Partner at Gilde Healthcare and responsible within Gilde Healthcare for coordinating the Impact Council, commented: "We are honoured to be working with such an established and experienced group of experts.
  • Pieter van der Meer, Managing Partner at Gilde Healthcare commented: "The Impact Council demonstrates our commitment to effectuate change in the healthcare sector.

Healthcare Courses by HIPAA Exams Now Available on 360training

Retrieved on: 
Friday, October 7, 2022
Registered nurse, LinkedIn, CDC, Joint Commission, Infection, Atmosphere of Earth, Scripps, Organization, JC, HIPAA, Privacy, Hospital, Massachusetts General Hospital Psychiatry Academy, Twitter, Carl Zeiss Meditec, Technology, OSHA, Food, John Vane, Health, Foodservice, Social media, United, Real estate, Financial services, TIPS, Compliance, Medicine, Nursing, Health care, Facebook

AUSTIN, Texas, Oct. 7, 2022 /PRNewswire/ --360training has officially stepped into providing regulatory and compliance training for Healthcare after acquiring HIPAA Exams in April of 2022.

Key Points: 
  • AUSTIN, Texas, Oct. 7, 2022 /PRNewswire/ --360training has officially stepped into providing regulatory and compliance training for Healthcare after acquiring HIPAA Exams in April of 2022.
  • It has launched 46 HIPAA , Nursing , and Infection Control courses as part of its new Healthcare Vertical .
  • Their up-to-date, comprehensive catalog of IACET-approved courses safeguard patient privacy, meeting HIPAA, OSHA, and CDC standards.
  • In addition to courses for healthcare workers, 360training's healthcare vertical has courses for business associates and administrators, sales professionals, and general staff members.